首页 › 基金 › SHENKMAN CAPITAL MANAGEMENT INC › RGEN
SHENKMAN CAPITAL MANAGEMENT INC 对 RGEN 的持仓历史
Repligen Corp · 医疗保健
SHENKMAN CAPITAL MANAGEMENT INC 在 Q3 2026 的 13F 申报中披露持有 RGEN(Repligen Corp)5,183,000 股,市值约 US$6.2M,约占其申报组合的 1.26%,在其申报持仓中市值排名第 22 位。 SHENKMAN CAPITAL MANAGEMENT INC 最近 8 个申报季度中有 8 个季度披露了 RGEN 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
SHENKMAN CAPITAL MANAGEMENT INC 对 RGEN 的持仓演变
SHENKMAN CAPITAL MANAGEMENT INC 于 Q4 2024 首次披露 RGEN 持仓:4,199,000 股(约 US$4.4M)。 该持仓在 Q2 2026 达到峰值 12,478,000 股,市值约 US$13.0M。 在 8 次申报中,SHENKMAN CAPITAL MANAGEMENT INC 6 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 5,183,000 股、市值约 US$6.2M,环比减持 -7,295,000 股。。 持仓曾出现大幅变动:Q1 2025 增持约 95% (随后一个季度股价下跌 2%)、Q3 2026 减持约 58% (随后一个季度股价下跌 13%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 4.20M | $4.44M | 新进 |
| Q1 2025 | 8.18M | $8.31M | 增持 |
| Q2 2025 | 8.88M | $8.90M | 增持 |
| Q3 2025 | 9.47M | $9.75M | 增持 |
| Q4 2025 | 10.11M | $11.32M | 增持 |
| Q1 2026 | 11.36M | $11.31M | 增持 |
| Q2 2026 | 12.48M | $13.05M | 增持 |
| Q3 2026 | 5.18M | $6.21M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RGEN 与 13F 数据
RGEN(Repligen Corp)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 RGEN,申报仓位最大的包括:UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick 资本 (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RGEN 的基金
- UNITED CAPITAL FINANCIAL ADVISORS, LLC 2.79M 股 · $536.33M · Q3 2026
- Maverick 资本 1.98M 股 · $270.77M · Q2 2026
- MAVERICK CAPITAL LTD 1.98M 股 · $270.77M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.24M 股 · $239.02M · Q3 2026
- CONGRESS ASSET MANAGEMENT CO 1.02M 股 · $196.25M · Q3 2026
- Stephens Investment Management Group LLC 954.52K 股 · $183.49M · Q3 2026
- WASATCH ADVISORS LP 907.16K 股 · $174.38M · Q3 2026
- RTW INVESTMENTS, LP 1.24M 股 · $169.27M · Q2 2026
- Conestoga Capital Advisors, LLC 700.63K 股 · $134.68M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 591.71K 股 · $113.74M · Q3 2026
- FRED ALGER MANAGEMENT, LLC 733.74K 股 · $100.11M · Q2 2026
- DeepCurrents Investment Group LLC 94.44M 股 · $96.80M · Q2 2026
更多关于 SHENKMAN CAPITAL MANAGEMENT INC
常见问题
How long has SHENKMAN CAPITAL MANAGEMENT INC held RGEN?
SHENKMAN CAPITAL MANAGEMENT INC has disclosed RGEN holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is SHENKMAN CAPITAL MANAGEMENT INC's current position in RGEN?
As of Q3 2026, SHENKMAN CAPITAL MANAGEMENT INC holds 5.18M shares of RGEN (Repligen Corp), valued at $6.21M, representing 1.26% of its reported portfolio and ranking #22.
Has SHENKMAN CAPITAL MANAGEMENT INC been buying or selling RGEN?
In the latest 13F filing (Q3 2026), SHENKMAN CAPITAL MANAGEMENT INC reduced its position in RGEN. The position peaked in Q2 2026 at 12.48M shares.
Which other funds hold RGEN?
Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick 资本, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.